AASM: Multicomponent CBT Recommended for Chronic Insomnia
WEDNESDAY, Dec. 23, 2020 -- Multicomponent cognitive behavioral therapy is strongly recommended for the treatment of chronic insomnia in adults, according to a new clinical practice guideline issued by the American Academy of Sleep Medicine and published online Nov. 9 in the Journal of Clinical Sleep Medicine.
Jack D. Edinger, Ph.D., from National Jewish Health in Denver, and colleagues conducted a systematic literature review to evaluate the relevant literature and quality of evidence to develop recommendations for behavioral and psychological treatments for chronic insomnia disorder in adults.
The authors strongly recommend that clinicians use multicomponent cognitive behavioral therapy for treatment of chronic insomnia disorder in adults. Conditional recommendations include use of stimulus control, sleep restriction therapy, and relaxation therapy as single-component therapies for treatment of chronic insomnia disorder in adults. Sleep hygiene is not recommended for use as a single-component therapy for treatment of chronic insomnia disorder.
"Although sleep hygiene practices are often suggested and well understood by patients, sleep hygiene [recommendations] do not constitute an effective stand-alone therapy," Edinger said in a statement.
Several authors disclosed financial ties to the pharmaceutical and medical technology industries.
© 2021 HealthDay. All rights reserved.
Posted: December 2020
Read this next
WEDNESDAY, Jan. 6, 2021 -- Frequent nightmares can occur in some patients hospitalized with cardiovascular (CV) diseases and are associated with depression, anxiety, and insomnia,...
MONDAY, Dec. 28, 2020 -- Longer time to fall asleep is associated with greater subsequent cognitive decline among middle-aged Hispanic adults, according to a study published...
THURSDAY, Dec. 10, 2020 -- Sleep-related impairment among physicians is associated with increased burnout, decreased professional fulfillment, and increased self-reported...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.